These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11956599

  • 1. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
    Hata H, Uenaka A, Takada I, Kenjo A, Takahashi M, Ono T, Fujita T, Nakayama E.
    Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
    [Abstract] [Full Text] [Related]

  • 2. Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
    Takada I, Noguchi Y, Kenjo A, Wada H, Uenaka A, Fujita T, Inoue H, Nakayama E.
    Cancer Sci; 2004 Mar; 95(3):254-9. PubMed ID: 15016326
    [Abstract] [Full Text] [Related]

  • 3. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M, Wada H, Honda S, Tawara I, Uenaka A, Kanematsu T, Nakayama E.
    J Immunol; 1999 Jun 01; 162(11):6420-5. PubMed ID: 10352255
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
    Manki A, Ono T, Uenaka A, Seino Y, Nakayama E.
    Cancer Res; 1998 May 01; 58(9):1960-4. PubMed ID: 9581839
    [Abstract] [Full Text] [Related]

  • 5. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.
    Yokoi T, Uenaka A, Ono T, Onizuka S, Inoue H, Nakayama E.
    Int Immunol; 1997 Aug 15; 9(8):1195-201. PubMed ID: 9263017
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ, Costelloe EO, Fitzpatrick DR, Haanen JB, Schumacher TN, Brown LE, Kelso A.
    Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2657-62. PubMed ID: 12601154
    [Abstract] [Full Text] [Related]

  • 15. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA, Greenberg PD, Fefer A.
    Cancer Res; 1981 Jul 04; 41(7):2658-63. PubMed ID: 7018668
    [Abstract] [Full Text] [Related]

  • 16. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA, Ciavarra R, Riblet R, Forman J.
    J Immunol; 1984 Nov 04; 133(5):2778-85. PubMed ID: 6434638
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.
    Kloke O, Haubeck HD, Kölsch E.
    Eur J Immunol; 1986 Jun 04; 16(6):659-64. PubMed ID: 2424769
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ.
    Clin Cancer Res; 2002 Nov 04; 8(11):3561-9. PubMed ID: 12429647
    [Abstract] [Full Text] [Related]

  • 19. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 04; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 20. Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells.
    Ota S, Ono T, Morita A, Uenaka A, Harada M, Nakayama E.
    Cancer Res; 2002 Mar 01; 62(5):1471-6. PubMed ID: 11888922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.